美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,327.58

-9.1315-0.68%

涨家数：5

跌家数：15

平家数：- -

市盈率：- -

高：1,343.21

开：1,342.69

低：1,326.57

收：1,336.71

数据加载中...

总览新闻资讯

【吉利德科学与美国政府达成2亿美元和解协议】吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。

阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物

多款 FIC 生物新药首发 AACR ！来自阿斯利康、GSK、信达...

Insight数据库

阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物

吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元

阿斯利康盘中异动下午盘股价大涨3.02%报72.05美元

吉利德科学公司就医生回扣问题与美国达成 2.02 亿美元和解协议

BUZZ-辉瑞公司季度利润超预期，维持 2025 年预期；股价上涨

Co-Diagnostics, Inc.盘中异动急速拉升5.07%报0.390美元

更正后的简报-FDA 称肝素钠注射液，5000 [Usp'u]/1 毫升将因商业决定而停产 - 网站

美股异动丨辉瑞涨超3% Q1经调整每股盈利远超预期扩大成本削减力度

辉瑞盘中异动早盘快速拉升3.01%

辉瑞(PFE.N)涨近3%。

Aethlon Medical, Inc.盘中异动早盘股价大涨5.04%

Equillium, Inc.盘中异动股价大跌6.12%

新冠疫苗研发波折：Vaxart 获转机，行业仍陷困境

生物制品圈

Ibio, Inc.盘中异动快速上涨6.19%报1.12美元

Corvus Pharmaceuticals, Inc.盘中异动早盘股价大涨5.43%报3.69美元

美国食品和药物管理局局长称解雇不会妨碍该局的药物审查目标日期

BUZZ-辉瑞公司季度利润增长，维持 2025 年业绩预期

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=7&region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1327.5806,"timestamp":1746820799999,"preClose":1336.712,"halted":0,"volume":113582454,"delay":0,"changeRate":-0.006831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-9.13147,"latestTime":"05-09 16:00:00 EDT","open":1342.69,"high":1343.2052,"low":1326.5701,"amount":4653162209.902576,"amplitude":0.012445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.565313,"peRate":21.186942,"turnoverRate":0.007317,"increases":5,"decrements":15,"flats":0,"marketCap":1093969830401.5,"floatMarketCap":1075897192963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1343.2052,"amplitude":0.012445,"preClose":1336.712,"low":1326.5701,"pbRate":"3.565313","latestPrice":1327.5806,"volume":113582454,"delay":0,"open":1342.69,"prevYearClose":1274.8187,"prevWeekClose":1375.2667,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1375.2667,"twentyDayClose":1281.7616,"sixtyDayClose":1380.7908,"secType":"PLATE","market":"US","turnoverRate":0.007317,"peRate":21.186942,"marketCap":1093969830401.5,"floatMarketCap":1075897192963,"timestamp":1746820799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531749214","title":"【吉利德科学与美国政府达成2亿美元和解协议】吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531749214","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531749214?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:07","pubTimestamp":1745975247,"startTime":"0","endTime":"0","summary":"吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30090750029382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4550","LU0109394709.USD","IE00B3T34201.USD","LU1066053197.SGD","IE0002270589.USD","LU1839511570.USD","BK4585","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588","LU0234570918.USD","LU0320765992.SGD","IE00BKVL7J92.USD","BK4578","BK4568","LU1585245621.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4566","LU2087621335.USD","LU1066051498.USD","LU1571399168.USD","BK4139","BK4583","BK4532","GILD","LU0889565916.HKD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2531514749","title":"阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531514749","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531514749?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:03","pubTimestamp":1745975004,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AZN","LU0320765992.SGD","BK4585","BK4568","LU1829250122.USD","LU2417539215.USD","LU2456880835.USD","BK4588","LU0889565916.HKD","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2531727623","title":"多款 FIC 生物新药首发 AACR ！来自阿斯利康、GSK、信达...","url":"https://stock-news.laohu8.com/highlight/detail?id=2531727623","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531727623?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 08:43","pubTimestamp":1745973788,"startTime":"0","endTime":"0","summary":"2025 年 AACR 火热进行中。这次大会上，差不多有 50 款 FIC 生物新药首发亮相。据说今年这款产品就要启动首次人体临床试验了。GSK 和默克也不甘示弱，各自带来了一款 FIC 新药。信达是最多的，一口气公布了 4 款 FIC 新药，既有双抗、三抗，也有双抗 ADC和抗体类融合蛋白，药物类型特别丰富。另外，东阳光、菲鹏、辐联、启德、橙帆、塔吉瑞等十来家药企，也都在大会上展示了自家的 FIC 新药。最后，想要 2025 年 AACR 会议首发 FIC 新药清单的朋友，记得截图保存哦。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0889565916.HKD","AZN","LU2417539215.USD","BK4568","LU0320765992.SGD","GSK","BK4585","LU2462157665.USD","LU2456880835.USD","BK4588","BK4007","LU1829250122.USD","LU0109394709.USD","BK4532","GSK.UK"],"gpt_icon":0},{"id":"2531638715","title":"阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531638715","media":"第一财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531638715?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 05:45","pubTimestamp":1745963100,"startTime":"0","endTime":"0","summary":"　　英国当地时间4月29日，阿斯利康在最新季度的财报会议上透露，该公司可能会在中国面临一项新的罚款，金额达800万美元。　　阿斯利康表示，最新的罚款涉嫌进口乳腺癌药物Enhertu的未缴纳税款。该公司在上一季度财报会上称，因另外两款抗癌药物Imfinzi和Imjudo未缴税款，将面临最高450万美元的罚款。去年10月底，阿斯利康前中国总裁王磊因涉嫌走私被带走。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2417539215.USD","BK4568","LU2456880835.USD","BK4588","AZN","LU0320765992.SGD","LU1829250122.USD","BK4585","LU2462157665.USD","LU0109394709.USD","LU2236285917.USD","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531760523","title":"吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531760523","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531760523?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 02:31","pubTimestamp":1745951487,"startTime":"0","endTime":"0","summary":"更新版 1-吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元改写第一段；添加吉利德公司和美国律师的评论、指控、举报人详情、财务影响、署名Jonathan Stempel. 路透纽约4月29日 - 吉利德科学公司同意支付2.02亿美元，以了结一起举报人诉讼，该诉讼指控吉利德向同意开具其艾滋病药物处方的医生支付回扣，涉嫌民事欺诈。2024 年，吉利德的艾滋病药物销售总额达 196.1 亿美元，同比增长 8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R728V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU1066051498.USD","LU0289739699.SGD","LU1430594728.SGD","LU1585245621.USD","LU0109394709.USD","BK4568","IE00BSNM7G36.USD","IE0002270589.USD","BK4532","IE00BKVL7J92.USD","BK4583","LU2468319806.SGD","IE00B19Z3B42.SGD","BK4578","LU1839511570.USD","LU2087621335.USD","LU0320765992.SGD","BK4588","BK4566","GILD","LU2089984988.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","BK4585","BK4139","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0889565916.HKD","BK4550","LU0234570918.USD"],"gpt_icon":0},{"id":"2531762855","title":"阿斯利康盘中异动 下午盘股价大涨3.02%报72.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531762855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531762855?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 01:40","pubTimestamp":1745948447,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日01时40分，阿斯利康股票出现波动，股价大幅拉升3.02%。截至发稿，该股报72.05美元/股，成交量543.799万股，换手率0.18%，振幅3.30%。阿斯利康股票所在的制药行业中，整体涨幅为1.44%。该信息摘要如下：阿斯利康公布的2025年第一季度利润超出预期，并重申其全年业绩指引。财报显示，阿斯利康一季度总营收135.9亿美元，不及市场预期；核心每股收益为 2.49 美元，同比增长21%，超过分析师预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU2236285917.USD","LU2462157665.USD","BK4585","LU0889565916.HKD","LU2417539215.USD","AZN","BK4007","LU0109394709.USD","LU2456880835.USD","BK4588","LU1829250122.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2531764411","title":"吉利德科学公司就医生回扣问题与美国达成 2.02 亿美元和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2531764411","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531764411?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 01:39","pubTimestamp":1745948380,"startTime":"0","endTime":"0","summary":"吉利德科学公司就医生回扣问题与美国达成 2.02 亿美元和解协议路透纽约4月29日 - 美国曼哈顿检察官办公室周二表示，吉利德科学公司GILD.O已达成一项2.02亿美元的和解协议，以解决一起指控该公司向同意处方其艾滋病药物的医生支付回扣的民事欺诈诉讼。该和解协议解决了吉利德公司向参加吉利德公司演讲活动的医生支付酬金、餐费和差旅费，以诱使他们开具几种艾滋病药物处方的指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R7264:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0109394709.USD","IE00B3T34201.USD","LU1066053197.SGD","IE0002270589.USD","LU1839511570.USD","BK4585","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","BK4588","LU0234570918.USD","LU0320765992.SGD","IE00BKVL7J92.USD","BK4578","BK4568","LU1585245621.USD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4566","LU2087621335.USD","LU1066051498.USD","LU1571399168.USD","BK4139","BK4583","BK4532","GILD","LU0889565916.HKD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2531766955","title":"BUZZ-辉瑞公司季度利润超预期，维持 2025 年预期；股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2531766955","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531766955?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 00:41","pubTimestamp":1745944911,"startTime":"0","endTime":"0","summary":"** 由于 Paxlovid COVID-19 疗法销售额下降，PFE 第一季度营收不及预期，但该公司仍 坚持610 亿至 640 亿美元的财年营收预期。** 包括本交易日的走势在内，PFE 在今年已累计下跌约10(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R723X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","PFE","SG9999002232.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4007","BK4550","BK4588","LU0321505868.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0306806265.USD","LU1057294990.SGD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2531577377","title":"Co-Diagnostics, Inc.盘中异动 急速拉升5.07%报0.390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531577377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531577377?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 23:27","pubTimestamp":1745940471,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时27分，Co-Diagnostics, Inc.股票出现波动，股价快速上涨5.07%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.10%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。该公司还利用其专有技术为其 Co-Dx PCR 平台设计特定测试，并定位用于传染病以外应用的遗传标记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232751974a5c7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429232751974a5c7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2531752002","title":"更正后的简报-FDA 称肝素钠注射液，5000 [Usp'u]/1 毫升将因商业决定而停产 - 网站","url":"https://stock-news.laohu8.com/highlight/detail?id=2531752002","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531752002?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 23:24","pubTimestamp":1745940292,"startTime":"0","endTime":"0","summary":"更正后的简报-FDA 称肝素钠注射液，5000 [Usp'u]/1 毫升将因商业决定而停产 - 网站来源更正为美国食品及药物管理局，而非辉瑞公司路透4月29日 - 美国食品和药物管理局：FDA：肝素钠，注射剂，5000[USP'U]/1 毫升，因商业决定将停产 - 网站(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R71YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU1066051498.USD","LU0321505439.SGD","LU1057294990.SGD","LU0985481810.HKD","LU0058720904.USD","SG9999011175.SGD","LU0868494617.USD","SG9999001176.SGD","BK4592","BK4534","LU1894683264.USD","BK4568","LU0321505868.SGD","BK4588","IE0002270589.USD","BK4007","IE00B19Z3581.USD","SG9999002232.USD","LU0234572021.USD","BK4599","LU0225771236.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU0170899867.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU1066053197.SGD","SG9999001176.USD","BK4581","BK4585","IE00BLSP4452.SGD","BK4533","LU0306807586.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU1023059063.AUD","LU1883839398.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0122379950.USD","LU0456855351.SGD","SG9999003800.SGD","BK4550","SG9999013999.USD"],"gpt_icon":0},{"id":"2531757594","title":"美股异动丨辉瑞涨超3% Q1经调整每股盈利远超预期 扩大成本削减力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757594","media":"格隆汇APP","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531757594?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 23:11","pubTimestamp":1745939460,"startTime":"0","endTime":"0","summary":"格隆汇4月29日｜辉瑞(PFE.US)涨超3%，报23.755美元。消息面上，辉瑞周二公布，在加大成本削减力度下，首季净利润同比跌约5%至29.7亿美元，经调整每股盈利92美仙，远高于市场预期的66美仙；营收同比跌8%至137.2亿美元，反映其抗病毒药物Paxlovid的收入减少。公司预计，通过两项成本削减措施，到2027年底将节省约77亿美元。公司维持对2025年全年财报的预期，预计销售额为610亿至640亿美元，惟补充该指引目前不包括与未来关税和贸易政策变化相关的任何潜在影响。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-29/doc-ineuwcvn0721829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999002224.SGD","SG9999003800.SGD","LU1894683348.USD","SG9999002232.USD","LU0058720904.USD","SG9999001176.SGD","IE0002270589.USD","LU0868494617.USD","IE00B19Z3581.USD","LU0289739699.SGD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4550","BK4588","LU0170899867.USD","BK4007","LU1066053197.SGD","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","IE000M9KFDE8.USD","BK4585","BK4581","BK4534","SG9999013999.USD","LU0234572021.USD","BK4599","LU0456855351.SGD","LU0321505439.SGD","LU0985481810.HKD","IE00BBT3K403.USD","BK4592","IE00BLSP4452.SGD","BK4533","LU0122379950.USD","LU1066051498.USD","LU0306806265.USD","LU1894683264.USD","PFE","SG9999011175.SGD","BK4568","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","LU0225771236.USD","SGXZ57979304.SGD","LU1883839398.USD"],"gpt_icon":0},{"id":"2531545567","title":"辉瑞盘中异动 早盘快速拉升3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531545567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531545567?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 22:50","pubTimestamp":1745938226,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时50分，辉瑞股票出现异动，股价急速拉升3.01%。截至发稿，该股报23.74美元/股，成交量3271.13万股，换手率0.58%，振幅5.53%。辉瑞股票所在的制药行业中，整体涨幅为1.01%。辉瑞公司简介：辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。与其他受贸易政策变化影响的公司不同，辉瑞并未调整其业绩预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429225026aa2c7e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429225026aa2c7e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","LU0321505868.SGD","LU1023059063.AUD","PFE","BK4585","BK4534","LU1057294990.SGD","SG9999002224.SGD","BK4007","LU0058720904.USD","BK4581","LU0868494617.USD","LU0306807586.USD","SG9999011175.SGD","BK4568","LU1066051498.USD","LU0456855351.SGD","BK4533","SG9999003800.SGD","LU0321505439.SGD","BK4599","LU0122379950.USD","LU1894683348.USD","LU0225771236.USD","BK4550","LU0306806265.USD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0289739699.SGD","LU1894683264.USD","LU0170899867.USD","LU1066053197.SGD","LU0985481810.HKD","SG9999001176.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU1883839398.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0234572021.USD","BK4588","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2531751539","title":"辉瑞(PFE.N)涨近3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531751539","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531751539?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 22:48","pubTimestamp":1745938133,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4534","BK4585","LU1023059063.AUD","LU1894683264.USD","LU0170899867.USD","LU0225771236.USD","LU1883839398.USD","SGXZ57979304.SGD","LU0985481810.HKD","LU0321505439.SGD","LU0321505868.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SG9999002224.SGD","BK4581","BK4599","LU0058720904.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4533","LU1066053197.SGD","SG9999001176.SGD","BK4007","SG9999003800.SGD","LU0225284248.USD","LU0234572021.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SG9999011175.SGD","BK4592","SG9999013999.USD","IE00BBT3K403.USD","LU1894683348.USD","SG9999001176.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU1057294990.SGD","IE0002270589.USD","BK4550","LU0306806265.USD","LU0306807586.USD","PFE","SG9999002232.USD","BK4568","LU0868494617.USD","LU0456855351.SGD","BK4588"],"gpt_icon":0},{"id":"2531755299","title":"Aethlon Medical, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531755299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531755299?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 22:07","pubTimestamp":1745935664,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时07分，Aethlon Medical, Inc.股票出现异动，股价急速拉升5.04%。截至发稿，该股报0.417美元/股，成交量2.6382万股，换手率0.16%，振幅3.78%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.45%。其相关个股中，Inspiremd Inc.、Autonomix Medical, Inc.、飞天兆业涨幅较大，Tivic Health Systems, Inc.、Invo Fertility, Inc.、Autonomix Medical, Inc.较为活跃，换手率分别为29.14%、20.66%、12.27%，振幅较大的相关个股有Tivic Health Systems, Inc.、Autonomix Medical, Inc.、Dih Holding Us, Inc.，振幅分别为18.01%、17.95%、15.10%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220744a46c4925&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220744a46c4925&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","TIVC","AEMD","BK4568","BK4082"],"gpt_icon":0},{"id":"2531275347","title":"Equillium, Inc.盘中异动 股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531275347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531275347?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:57","pubTimestamp":1745935059,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时57分，Equillium, Inc.股票出现异动，股价快速下跌6.12%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为1.40%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215741974a4142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215741974a4142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2531134867","title":"新冠疫苗研发波折：Vaxart 获转机，行业仍陷困境","url":"https://stock-news.laohu8.com/highlight/detail?id=2531134867","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531134867?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:56","pubTimestamp":1745935014,"startTime":"0","endTime":"0","summary":"近日，疫苗研发领域动态频出，Vaxart 公司迎来好消息，其新冠疫苗研究的暂停令被解除，研发进程得以重启。此前，HHS 在 2 月冻结了 Vaxart 的试验，这一举措使得该公司与政府签订的价值数十亿美元的口服新冠疫苗研发合同陷入僵局。其他公司受阻，研发之路艰难尽管 Vaxart 迎来转机，但其他新冠疫苗研发企业却仍在困境中挣扎。Vaxart 公司新冠疫苗研究的恢复为其带来了希望，但新冠疫苗研发行业整体仍面临监管、舆论等多方面的压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430052357a46cac01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430052357a46cac01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4009","BK4139","VXRT","HHS"],"gpt_icon":0},{"id":"2531312730","title":"Ibio, Inc.盘中异动 快速上涨6.19%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531312730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531312730?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:33","pubTimestamp":1745933617,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时33分，Ibio, Inc.股票出现异动，股价急速上涨6.19%。截至发稿，该股报1.12美元/股，成交量12.66万股，换手率1.26%，振幅3.81%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为1.92%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213337aa2c7e03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213337aa2c7e03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"gpt_icon":0},{"id":"2531410753","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.43%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531410753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531410753?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 21:32","pubTimestamp":1745933547,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时32分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.43%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为132.52%、39.26%、11.58%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ernexa Therapeutics Inc.、Promis Neurosciences Inc.，振幅分别为12.12%、12.10%、9.62%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213228aa2c7e00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213228aa2c7e00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVS","BK4139","BK4568"],"gpt_icon":0},{"id":"2531773684","title":"美国食品和药物管理局局长称解雇不会妨碍该局的药物审查目标日期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531773684","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531773684?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 20:42","pubTimestamp":1745930559,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局局长表示，尽管特朗普政府大规模解雇了该机构的人员，但美国食品和药物管理局仍将实现完成新药审查的目标。路透 4 月初报道称，该机构大规模解雇 了 对新药审评 至关重要的   员工，包括所有负责管理新产品申请等记录的 员工。马卡里还表示，他可以在该机构独立做出决定。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R71CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","BK4547","BK4568"],"gpt_icon":1},{"id":"2531641786","title":"BUZZ-辉瑞公司季度利润增长，维持 2025 年业绩预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531641786","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531641786?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 19:02","pubTimestamp":1745924560,"startTime":"0","endTime":"0","summary":"** 虽然第一季度营收不及预期，但仍坚持610-640亿美元的财年营收预期 ** 同时，维持 2.80 美元至 3.00 美元的财年每股收益预期。** 截至上次收盘，PFE 年累计下跌约 13 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R7114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","LU1894683264.USD","LU0225771236.USD","LU0321505868.SGD","IE0002270589.USD","BK4581","PFE","LU0058720904.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4592","SG9999002224.SGD","SG9999002232.USD","LU0289739699.SGD","LU1023059063.AUD","LU1883839398.USD","IE00BLSP4239.USD","BK4568","LU0306806265.USD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.SGD","LU0225284248.USD","LU0122379950.USD","BK4550","LU1057294990.SGD","LU0868494617.USD","BK4534","IE00B19Z3581.USD","LU1894683348.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4585","LU0321505439.SGD","LU0234572021.USD","SG9999011175.SGD","BK4533","BK4007","BK4599","BK4588","LU0306807586.USD","IE00BBT3K403.USD","SG9999001176.USD","LU1066053197.SGD","LU0985481810.HKD","LU0170899867.USD","SGXZ57979304.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":7,"totalSize":174,"code":"91000000","status":"200"}]}}